Answers are grounded in this paper and cite their sources.
A new anabolic steroid, norethandrolone (Nilevar), has recently been introduced for clinical use. This drug has been used successfully to reduce the hypercalcinuria associated with paralytic poliomyelitis.1Norethandrolone, 17a-ethyl-17-hydroxy-19-nor-4-androsten-3-one, is structurally intermediate between testosterone and estradiol. It has been shown to be a potent agent in reducing and reversing nitrogen catabolism.2However, at this service two of seven patients who received 1 mg. per kilogram of body weight per day of the drug over a period of several months developed jaundice. Report of Cases Case 1.— A 34-year-old engineer developed bulbospinal poliomyelitis in September, 1956. He required part-time respiratory aid. He was started on norethandrolone therapy, 20 mg. three times a day, on Dec. 20, 1956. He received this dosage intermittently over a period of 19 weeks, taking the drug for 14 weeks and being without it for one 3-week and two 1-week periods. On April
No takes yet. Share an insight, caveat, or question.
Marcelle F. Dunning (1958) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: